Table 2.

Correlation between anti‐Spike (S) antibody titers and IFN‐α, IFN‐ω, IFNAR1, IFNAR2, IRF9, ISG15, ISG56, IFI27, IL‐6, IL‐10, and TGF‐β mRNA levels before mAbs treatment (T0).

		IFN‐α	IFN‐ω	IFNAR1	IFNAR2	IRF9	ISG15	ISG56	IFI27	IL‐6	IL‐10	TGF‐β
Anti‐S antibody titers	r	.2586	.1564	.0426	.0404	−.2293	−.5327	−.4635	−.3940	−.0707	−.2201	−.0807
	p	.0183	.1580	.7024	.7166	.0370	<.0001	<.0001	.0002	.5252	.0456	.4681

Note: Data were analyzed using Spearman r correlation test and p < .05 were considered statistically significant.

Abbreviations: IFI27, IFN‐α‐inducible protein 27; IFN‐α, interferon‐α; IFN‐ω, interferon‐ω; IFNAR1, IFN‐α and ‐β receptor subunit 1; IFNAR2, IFN‐α and ‐β receptor subunit 1; IL‐6, interleukin‐6; IL‐10, interleukin‐10; IRF9, interferon regulatory factor 9; ISG15, interferon‐stimulated gene 15; ISG56, interferon‐stimulated gene 56; TGF‐β, transforming growth factor‐β; mAbs, monoclonal antibodies; mRNA, messenger RNA.